在神经退行性疾病中准N-甲基-d-酸盐受体
Allison Carles1, Aline Freyssin1,2, Florent Perin-Dureau2
1MMDN, University of Montpellier, EPHE, INSERM, Montpellier, France.
International journal of molecular sciences
|April 13, 2024
概括
N-甲基-D-酸盐受体 (NMDARs) 对大脑功能至关重要,影响记忆力和神经退行性疾病. 本综述详细介绍了NMDARs,它们在突触可塑性中的作用,以及治疗潜力,重点关注甲基 (FENM).
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- N-甲基-D-酸盐受体 (NMDARs) 是关键的离子转移性谷氨酸受体,对Ca2+的透性和刺激性神经传递至关重要.
- 这些由GluN1,GluN2和GluN3子单元组成的异构体受体在大脑中广泛存在,并调节突触传输,学习,记忆和可塑性等基本功能.
- NMDARs的失调与激发性毒性和神经退行性疾病 (如阿尔茨海默氏症,亨廷顿氏症和帕金森氏症) 有关.
研究的目的:
- 提供NMDAR结构,组成和本地化的全面审查.
- 阐明NMDARs在谷氨酸质突触中的作用和调节.
- 讨论NMDARs对认知过程,神经退行性疾病的影响,以及NMDAR对抗剂的治疗潜力,重点关注甲基 (FENM).
主要方法:
- 文献综述综合了NMDARs的当前知识.
- 详细检查NMDAR结构,子单元组成和突触局部化.
- 在认知过程和神经退行性疾病模型中分析NMDAR功能.
主要成果:
- 对于突触可塑性,学习和记忆,NMDARs至关重要.
- 异常的NMDAR功能有助于阿尔茨海默病,亨廷顿病和帕金森病的兴奋毒性和致病性.
- 甲基诺米曼丁 (FENM) 显示出作为阿尔茨海默病的神经保护剂,放射性追踪剂和抗焦虑剂的前景.
结论:
- NMDAR对正常大脑功能至关重要,并与各种神经系统疾病有关.
- 向NMDARs为认知增强和神经退行性疾病的治疗提供了治疗途径.
- 在神经系统疾病,特别是阿尔茨海默氏病中,FENM是一种有前途的多潜力的治疗药物.
相关概念视频
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
122
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
122
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K


